Guy Bar-Klein
AeroLeads people directory · profile

Guy Bar-Klein Email & Phone Number

Executive Director | Entrepreneur | Developing Novel Therapies and Biomarkers at Neurocentria, Inc.
Location: Walnut Creek, California, United States 11 work roles 4 schools
1 work email found @neurocentria.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email g****@neurocentria.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Executive Director | Entrepreneur | Developing Novel Therapies and Biomarkers
Location
Walnut Creek, California, United States

Who is Guy Bar-Klein? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Guy Bar-Klein is listed as Executive Director | Entrepreneur | Developing Novel Therapies and Biomarkers at Neurocentria, Inc., based in Walnut Creek, California, United States. AeroLeads shows a work email signal at neurocentria.com and a matched LinkedIn profile for Guy Bar-Klein.

Guy Bar-Klein previously worked as Executive Director of Research and Strategy at Neurocentria, Inc. and Director of Research at Neurocentria, Inc.. Guy Bar-Klein holds Postdoctoral Research Fellow, Neuroscience And Genetic Medicine from The Johns Hopkins University School Of Medicine.

Company email context

Email format at Neurocentria, Inc.

This section adds company-level context without repeating Guy Bar-Klein's masked contact details.

*@neurocentria.com
68% confidence

AeroLeads found 1 current-domain work email signal for Guy Bar-Klein. Compare company email patterns before reaching out.

Profile bio

About Guy Bar-Klein

I am a neuroscientist and executive, trained by world-leading experts from Johns Hopkins University School of Medicine, Howard Hughes Medical Institute, UC Berkeley, Halifax University and BGU.I identified key mechanisms leading to neurodegeneration and neuronal rewiring, developed novel biomarkers and discovered innovative therapies (TBI, stroke, epilepsy, SCA3, AD, ADHD, MDD), including the first treatment for preventing the development of epilepsy (epileptogenesis). Hold extensive financial and budgetary experience; planned and managed of multi-million-dollar projects and budgets.Currently serving as the Executive Director of Research & Strategy at Neurocentria, a late-phase biotech company, leading the company’s programs in ADHD (phase 3), MDD (phase 3) and Alzheimer’s disease (phase 2b), as well as translational research and regulatory affairs, with a track record of three approved INDs.Known for extensive scientific and management expertise with polished people skills. Recognized for creating team-oriented environments with a high level of dedication, projects management and time-line oriented outcome. Out-of-the-box, analytic thinker with outstanding oral and written communication skills. Promoted to positions of increasing authority and responsibility due to strong leadership skills, research capabilities and overall performance.My true passion is to bring life-changing therapies for those with great unmet medical need and their families using revolutionary science and pioneering programs. This drives me to excellence with unlimited internal motivation.You are invited to contact me via a direct message or at guy.bar@gmail.com.

Listed skills include Research, Microsoft Office, Teaching, Budgets, and 48 others.

Current workplace

Guy Bar-Klein's current company

Company context helps verify the profile and gives searchers a useful next step.

Neurocentria, Inc.
Neurocentria, Inc.
Executive Director | Entrepreneur | Developing Novel Therapies and Biomarkers
AeroLeads page
11 roles

Guy Bar-Klein work experience

A career timeline built from the work history available for this profile.

Executive Director Of Research And Strategy

Current

Walnut Creek, California, Us

Jan 2023 - Present

Director Of Research

Walnut Creek, California, Us

Apr 2021 - Jan 2023

Manager, Research And Development

Walnut Creek, California, Us

Jun 2020 - Apr 2021

Post-Doctoral Research Associate

Chevy Chase, Maryland, Us

• Investigated novel approaches/potential treatments for genetic diseases of the central nervous system and connective tissues, neurodegenerative and neuromuscular disorders, cerebrovascular lesions, aortic root aneurysms and aortic valve defects.• Identified novel treatments for the prevention of proteins aggregation and dysfunctional autophagy in spinocerebellar ataxia 3.• Established and implemented innovative AAV-based neuromodulation treatment for epilepsy in collaboration with external groups.• Modified critical tissue clearing technics used in neuroscience, introduced and adapted them for compatibility with cardiac tissue and vasculature.• Developed and introduced a creative new approach for imaging large volume, intact cardio-vascular tissues.

Sep 2015 - Jun 2020

Post-Doctoral Research Fellow

Baltimore, Md, Us

• Investigated novel approaches/potential treatments for genetic diseases of the central nervous system and connective tissues, neurodegenerative and neuromuscular disorders, cerebrovascular lesions, aortic root aneurysms and aortic valve defects.• Identified novel treatments for the prevention of proteins aggregation and dysfunctional autophagy in spinocerebellar ataxia 3.• Established and implemented innovative AAV-based neuromodulation treatment for epilepsy in collaboration with external groups.• Modified critical tissue clearing technics used in neuroscience, introduced and adapted them for compatibility with cardiac tissue and vasculature.• Developed and introduced a creative new approach for imaging large volume, intact cardio-vascular tissues.

Sep 2015 - Jun 2020

Post-Doctoral Research Fellow

Ben-Gurion University Of The Negev

• Promoted to positions of increasing authority and responsibility due to exemplary performance and strong scientific knowledge. • Developed essential predicting strategies and biomarkers for post-traumatic epilepsy, enabling diagnosis of at-risk patients and monitor the efficacy of various therapies with 92.86% success rate.• Designed clinically relevant MRI-based diagnostic and pharmacodynamic biomarkers for epileptogenesis.• Spearheaded an innovative translational research project for discovering new therapies and improving treatment protocols for preventing neurological complications following poisoning.• Directed and supervised a multinational, multi-disciplinary team of up to 14 experts within smaller groups, leading projects as the first author to an extensive publishing record in high impact journals.

Jan 2015 - Sep 2015

Teaching Assistant

Ben-Gurion University Of The Negev

• Created and implemented innovative lesson plans for providing frontal teaching and laboratory instruction for various courses such as human physiology for 255 bio-medical engineering, pharmacy and medical laboratory sciences students and neural basis of cognition for ~30 graduate students.• Conducted office hours for students to provide extra assistance and review exams, driving optimal student achievement.• Actively engaged in various professional meetings, educational conferences and teacher training workshops to maintain and improve professional competence.

Oct 2011 - Dec 2014

Researcher

Ben-Gurion University Of The Negev

• Investigated leading mechanisms for post-injury epilepsy and potential preventive therapies employing biochemical assays, video-EEG monitoring and imaging techniques.• Identified key factors in the development of epilepsy and designed a first-in-class preventive treatment for epileptogenesis.• Mentored 11 students and managed 6 technical employees in research projects while monitoring for top performance. • Served as a vital member of the multicenter international research group participating in various collaborations with defense forces and contractors on essential translational research projects.

Oct 2008 - Dec 2014

Research Assistant

Ben-Gurion University Of The Negev

• Functioned as a core member of the international research group aiming to identify crucial signaling in epileptogenesis.• Built and introduced a detailed model for a long term in-vivo monitoring of epileptogenesis assuring the project was completed on time and exceeded expectations. • Complied with all applicable safety policies, practices and procedures within the lab. • Developed, improved and customized samples, equipment, processes and analytical methods.

Nov 2007 - Oct 2008

Budget Planning & Management Specialist

Tel-Aviv, Il

• Planned and managed the information unit’s annual budget of $6M including preparing and producing an accurate budget report for up to 20 of the information unit’s businesses/customers.• Cultivated, managed and maintained strong working relationships with external vendors and internal stakeholders to drive continued business growth. • Utilized strong analytical and conflict resolution skills to identify, track, report and resolve critical issues in a timely manner.• Employed strong problem solving and creative/critical thinking skills to understand business needs and translate them into appropriate solutions.

Oct 2004 - Nov 2007

Information Technologies Specialist

Tel-Aviv, Il

• Oversaw all aspects of data cleansing within the information systems unit assuring 100% accuracy.• Assisted in characterizing unique, tailor-made information systems for diverse headquarter departments and business units to enhance organizational efforts. • Recommended changes in development, maintenance and system standards to senior management and key stakeholders.• Consistently exceeded expectations ensuring projects were on time, compliant to standards and met business needs.

Sep 2003 - Oct 2004
4 education records

Guy Bar-Klein education

Postdoctoral Research Fellow, Neuroscience And Genetic Medicine

The Johns Hopkins University School Of Medicine

Doctor Of Philosophy (Ph.D.), Neurophysiology

Ben-Gurion University Of The Negev

Master Of Medical Sciences (M.Med.Sc.), Neurophysiology

Ben-Gurion University Of The Negev

Bachelor Of Science (B.Sc.), Biophysics

Bar-Ilan University
FAQ

Frequently asked questions about Guy Bar-Klein

Quick answers generated from the profile data available on this page.

What company does Guy Bar-Klein work for?

Guy Bar-Klein works for Neurocentria, Inc..

What is Guy Bar-Klein's role at Neurocentria, Inc.?

Guy Bar-Klein is listed as Executive Director | Entrepreneur | Developing Novel Therapies and Biomarkers at Neurocentria, Inc..

What is Guy Bar-Klein's email address?

AeroLeads has found 1 work email signal at @neurocentria.com for Guy Bar-Klein at Neurocentria, Inc..

Where is Guy Bar-Klein based?

Guy Bar-Klein is based in Walnut Creek, California, United States while working with Neurocentria, Inc..

What companies has Guy Bar-Klein worked for?

Guy Bar-Klein has worked for Neurocentria, Inc., Howard Hughes Medical Institute, Johns Hopkins School Of Medicine, Ben-Gurion University Of The Negev, and Teva Pharmaceuticals.

How can I contact Guy Bar-Klein?

You can use AeroLeads to view verified contact signals for Guy Bar-Klein at Neurocentria, Inc., including work email, phone, and LinkedIn data when available.

What schools did Guy Bar-Klein attend?

Guy Bar-Klein holds Postdoctoral Research Fellow, Neuroscience And Genetic Medicine from The Johns Hopkins University School Of Medicine.

What skills is Guy Bar-Klein known for?

Guy Bar-Klein is listed with skills including Research, Microsoft Office, Teaching, Budgets, Editing, Team Building, Project Planning, and Project Management.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.